Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
business development
Pharma
To enter sleep market, Alkermes forks over $2.1B for Avadel
Alkermes has ponied up $2.1 billion to acquire Avadel Pharmaceuticals, hoping to gain an immediate growth driver in narcolepsy drug Lumryz.
Kevin Dunleavy
Oct 22, 2025 12:04pm
New Incyte CEO takes 'fresh look' at business, outlines BD plan
Aug 4, 2025 11:16am
AbbVie will continue to pursue external innovation for long-term
Jul 31, 2025 11:44am
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Jun 13, 2025 9:18am
Amid ongoing launches, Novo eyes rare disease leadership
Mar 7, 2025 9:20am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
